Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal Bupivacaine with Tramadol or Dexmedetomidine for Post-Laparoscopic Analgesia
NCT04813016Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tramadol, dexmedetomidine in postoperative pain, sponsored by National Cancer Institute. Started Mar 2021; status: completed.
02
Drugs
tramadoldexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04813016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04813016.